Same Ribosomal Protein Messenger RNAs as Colonic Gastric and Hepatocellular Carcinomas Do Not Overexpress the Updated Version

نویسندگان

  • Graham F. Barnard
  • Raymond J. Staniunas
  • Masaki Mori
  • Mark Puder
  • Milburn J. Jessup
  • Glenn D. Steele
  • Lan Bo Chen
چکیده

The levels of a number of ribosomal protein mRNAs are reported to be increased in human colon cancer. We have assessed whether selected ribosomal protein mRNAs are overexpressed in other gastrointestinal malignancies, namely gastric and hepatocellular carcinomas. Subtracted complementary DNA libraries were generated from paired samples of human (a) coloréela!carcinoma minus adjacent normal colonie mucosa and (hi hepatocellular carcinoma minus adjacent normal liver. Screening of—3% of these library clones determined that ribosomal protein mRNAs encoding L18 and L37 (not previously reported) and PO and S6 were overexpressed in one or the other library. Their complementary DNA inserts were then used as probes to evaluate their expression in a larger number of paired tumor/normal surgical samples of human colonie, gas tric, and hepatocellular carcinomas, by Northern hybridization. The inKNA signal was greater in the colonie carcinoma than in paired adjacent normal colonie mucosa in 38 of 42 cases for PO [tumor/normal (T/N) ratio = 3.0 ±0.3, mean ±SE, P < 0.001] (G. F. Barnard, R. J. Staniunas, S. Bao, K. Mudine. J. L. Gollan, G. D. Steele, Jr., and L. B. Chen, Cancer Res., 52: 3067-3072, 1992), in 25 of 28 cases for L18 (T/N ratio = 3.7 ±0.5, P < 0.001), in 27 of 28 cases for L37 (T/N ratio = 5.3 ±0.4, P < 0.001), and in 24 of 28 cases for S6 (T/N ratio = 3.1 i 0.5, P < 0.01 ). The level of mRNA overexpression of L18 and S6 did not correlate with the Dukes' stage of disease. In hepatocellular carcinoma samples, using the same four ribo somal protein complementary DNA probes, only PO mRNA was signifi cantly increased (T/N ratio = 2.8 ±0.4, n = 6, P = 0.047). In gastric carcinoma samples, none of these mRNAs was increased (mean T/N ratios = 0.9—1.2,n = 6). Therefore, gastric and hepatocellular carcinomas do not overexpress the same ribosomal protein mRNAs as do colonie carcinoma.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

ریبو نوکلئیک اسیدها (RNAs) در اسپرم بالغ

 The nucleus of mature sperm contains a complex population of transcripts such as mRNAs and miRNAs which expressed and accumulated during process of spermatogenesis however in spermatozoa, transcription is inert. The spermatozoa do not have cytoplasmic ribosomal compounds and translation apparatus. However, spermatozoa can translate cytoplasmic mRNAs de novo, using mitochondrial poly...

متن کامل

Expression of epidermal growth factor receptor in human gastric and colonic carcinomas.

The expression of epidermal growth factor (EGF) receptor was examined immunohistochemically in a total of 122 gastric and 61 colonic carcinomas, out of which 16 gastric and 8 colonic carcinomas were also examined by 125I-labeled EGF binding analysis and Western blotting. The values of EGF binding were 12.68 +/- 1.98 (SE; n = 16) fmol/mg protein in gastric carcinomas and 5.72 +/- 2.15 (n = 8) fm...

متن کامل

SURVEY AND SUMMARY Experimental approaches to identify non-coding RNAs

Cellular RNAs that do not function as messenger RNAs (mRNAs), transfer RNAs (tRNAs) or ribosomal RNAs (rRNAs) comprise a diverse class of molecules that are commonly referred to as non-protein-coding RNAs (ncRNAs). These molecules have been known for quite a while, but their importance was not fully appreciated until recent genome-wide searches discovered thousands of these molecules and their ...

متن کامل

Tissue-specific cadherin CDH17 is a useful marker of gastrointestinal adenocarcinomas with higher sensitivity than CDX2.

Cadherin 17 (CDH17) is a cell adhesion molecule expressed in intestinal epithelium and transcriptionally regulated by CDX2. We compared the usefulness of CDH17 as an immunohistochemical intestinal marker to that of CDX2 in gastrointestinal and extragastrointestinal carcinomas and nonneoplastic tissues. Nonneoplastic intestinal and pancreatic duct epithelia were CDH17-positive. Most esophageal (...

متن کامل

Ursodeoxycholic acid and its emerging role in attenuation of tumor growth in gastrointestinal malignancies

Dear Editor, I read with great interest the recent article by Tschirner et al. [1]. Interestingly, recent data suggest that ursodeoxycholic acid (UDCA) may attenuate tumor growth in a number of gastrointestinal malignancies. For instance, tauro-ursodeoxycholic acid when administered along with celecoxib attenuates proliferation and tumor growth in colonic adenomas [2]. Interestingly, UDCA decre...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 1993